diaziquone has been researched along with Hematologic Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creagan, ET; Eagan, RT; Frytak, S; Nichols, WC | 1 |
Baker, LH; Decker, DA; Haas, CD; Samson, MK | 1 |
Camacho, FJ; Chang, AY; Ettinger, DS; Finkelstein, DM; Harper, GR; Marsh, JC; Ruckdeschel, JC; Silber, R; Wolter, JM | 1 |
Bender, JF; Erlichman, C; Grillo-López, J; Neidhart, JA; Robert, F; Velez-Garcia, E | 1 |
Baker, LH; Balcerzak, SP; Rivkin, SE; Stephens, RL; Zidar, BL | 1 |
2 trial(s) available for diaziquone and Hematologic Diseases
Article | Year |
---|---|
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
Topics: Aclarubicin; Aged; Anaphylaxis; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Naphthacenes | 1985 |
Phase II trial of diaziquone in patients with colon cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Clinical Trials as Topic; Colonic Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged | 1985 |
3 other study(ies) available for diaziquone and Hematologic Diseases
Article | Year |
---|---|
Phase II study of diaziquone in patients with advanced carcinoma of the lung.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1984 |
Phase II clinical evaluation of AZQ in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1984 |
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms | 1985 |